cytokine release syndrome – Discover Pharma

Welcome to Discover Pharma! Today is : March 16, 2026

cytokine release syndrome

Cell & Gene Therapy,Clinical studies,Clinical Trials,Events and Conferences,Hematology,Oncology,Pharmaceuticals and therapeutics
CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting
CytoAgents will present new clinical safety data for CTO1681 at [...]

December 3, 2025
Clinical Development,Clinical studies,Clinical Trials,Oncology,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development
CytoAgents receives fourth NIH grant to advance research on cytokine release syndrome in CAR T-cell therapy
CytoAgents, a clinical-stage biotechnology company developing an oral small-molecule immune [...]

October 7, 2025
Biologics & Biosimilars,Clinical Trials,Oncology,Pharmaceuticals and therapeutics,Rare Diseases,Research & Development
Poolbeg secures free supply of bispecific antibody for POLB 001 trial at The Christie
Poolbeg Pharma has appointed Accelerating Clinical Trials (ACT) to run [...]

September 25, 2025
Biologics & Biosimilars,Clinical Trials,Patient Centricity
Poolbeg receives FDA Orphan Drug Designation for POLB 001
Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]

May 27, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK